Members

Albert Alier Fabrego (Researcher)

Gema Carretero García (Technician)

Alicia González Mena (Researcher)

Santiago Grau Cerrato (Researcher)

Ana Guelar Grimberg (Researcher)

Roberto Carlos Güerri Fernández (Researcher)

Hernando Knobel Freud (Researcher)

Elisabet Lerma Chippirraz (Technician)

Sònia Luque Pardos (Researcher)

María Milagro Montero (Researcher)

Lluís Puig Verdié (Researcher)

Francisca Sánchez Martínez (Researcher)

M. Luisa Sorli Redó (Researcher)

Judith Villar García (PhD Student)

• Main Publications
• Ongoing Research Projects
• Participation in Research Networks

• Clinical Trials Signed in 2016
• Theses
• Other

Main Publications

• Benito N, Franco M, Ribera A, Soriano A, Rodríguez-Pardo D, Sorli L, Fresco G, del Toro MD, Guio L, Sánchez-Rivas E, Bahamande A, Riera M, Esteban J, Etxaburu JM, Martínez-Álvarez J, Jover-Sáenz A, Dueñas C, Ramos A, Sobrino B, Euba G, Morata L, Pigrau C, Coll P, Mur I, Ariza J, REIPI (Spanish Network for Research in Infectious Disease) Group for the Study of Prosthetic Joint Infections. Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study. Clin Microbiol Infec 2016; 22(8): 732.e1-732.e8. IF 4.575. Q1.

• Cuervo G, Gasch O, Shaw E, Camoez M, Domínguez MA, Padilla B, Pintado V, Almirante B, Lepe JA, López-Medrano F, Ruiz de Gopegui E, Martínez JA, Montejo JM, Pérez-Nadales E, Arnáiz A, Goenaga MA, Benito N, Horcajada JP, Rodríguez-Baño J, Pujol M, On behalf of the REIPI/GEIH study group (...Montero M, Salvadó M...). Clinical characteristics, treatment and outcomes of mrsa bacteraemia in the elderly. J Infection 2016; 72(3): 309-316. IF 4.382. Q1.

• Curran A, Rojas J, Cabello A, Troya J, Imaz A, Domingo P, Martínez E, Ryan P, Górgolas M, Podzamczer D, Knobel H, Gutiérrez F, Ribera E. Effectiveness and safety of an abacavir/lamivudine+rilpivirine regimen for the treatment of HIV-1 infection in naive patients. J Antimicrob Chemother 2016; 71(12): 3510-3514. IF 4.919. Q1.

• García-de-Lorenzo A, Luque S, Grau S, Agrifoglio A, Cachafeiro L, Herrero E, Asensio MJ, Sánchez SM, Roberts JA. Comparative population plasma and tissue pharmacokinetics of micafungin in critically ill patients with severe burn injuries and patients with complicated intra-abdominal infection. Antimicrob Agents Chemother 2016; 60(10): 5914-5921. IF 4.415. Q1.

• Grau S, Luque S, Echeverría-Esnal D, Sorli L, Campillo N, Montero M, Álvarez-Lerma F, Plasencia V, Horcajada JP. Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp. Int J Antimicrob Ag 2016; 48(2): 212-214. IF 4.097. Q1.

• Güerri-Fernández R, Villar-García J, Prieto-Alhambra D, Mellibovsky L, Nogués X, González-Mena A, Guelar A, Trenchs-Rodríguez M, Herrera-Fernández S, Horcajada JP, Díez-Pérez A, Knobel H. HIV infection is associated with worse bone material properties, independently of bone mineral density. JAIDS-J Acq Immun Def Synd 2016; 72(3): 314-318. IF 3.806. Q1.

• Horcajada JP, Sorli L, Luque S, Benito N, Segura C, Campillo N, Montero M, Esteve E, Mirelis B, Pomar V, Cuquet J, Martí C, Garro P, Grau S. Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate. Int J Antimicrob Ag 2016; 48(6): 725-727. IF 4.097. Q1.

• López-Medrano F, Fernández-Ruiz M, Silva JT, Carver PL, van Delden C, Merino E, Pérez-Sáez MJ, Montero M, Coussement J, de Abreu Mazzolin M, Cervera C, Santos L, Sabé N, Scemla A, Cordero E, Cruzado-Vega L, Martín-Moreno PL, et al. Clinical presentation and determinants of mortality of invasive pulmonary aspergillosis in kidney transplant recipients: a multinational cohort study. Am J Transplant 2016; 16(11): 3220-3224. IF 5.669. Q1.

• López-Medrano F, Silva JT, Fernández-Ruiz M, Carver PL, van Delden C, Merino E, Pérez-Sáez MJ, Montero M, Coussement J, de Abreu Mazzolin M, Cervera C, Santos L, Sabé N, Scemla A, Cordero E, Cruzado-Vega L, Martín PL, et al. Risk factors associated with early invasive pulmonary aspergillosis in kidney transplant recipients: results from a multinational matched case-control study. Am J Transplant 2016; 16(7): 2148-2157. IF 5.669. Q1.

• Merino I, Shaw E, Horcajada JP, Cercenado E, Mirelis B, Pallarés MA, Gómez J, Xercavins M, Martínez-Martínez L, de Cueto M, Cantón R, Ruiz-Garbajosa P, on behalf of the ITUBRAS-GEIH-SEIMC Group. CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain. J Antimicrob Chemother 2016; 71(8): 2125-2130. IF 4.919. Q1.

• Pérez-García A, Landecho MF, Beunza JJ, Conde D, Horcajada JP, Grau S, Gea A, Mauleón E, Sorli L, Gómez J, Terradas R, Lucena JF, Alegre F, Huerta A, del Pozo JL. Enterococcal bloodstream infection. Design and validation of a mortality prediction rule. Int J Clin Pract 2016; 70(2): 147-55. IF 2.226. Q1.